ID

34247

Descripción

Equivalence of Intramuscular (IM) Versus Subcutaneous (SC) Applications of Long Acting Pamorelin 11.25 mg; ODM derived from: https://clinicaltrials.gov/show/NCT01257425

Link

https://clinicaltrials.gov/show/NCT01257425

Palabras clave

Versiones (1)
  1. 15/1/19 15/1/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

15 de enero de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT01257425

Inglés

Eligibility Prostate Cancer NCT01257425

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically proven prostate cancer, locally advanced or metastatic, or rising psa (prostate-specific antigen) after failed local therapy, and the patient scheduled to receive androgen deprivation therapy
Descripción

Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | Raised prostate specific antigen | Status post Local Therapy failed | Antiandrogen therapy Scheduled

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0205179
UMLS CUI [1,3]
C1517927
UMLS CUI [2]
C0936223
UMLS CUI [3]
C0178415
UMLS CUI [4,1]
C0231290
UMLS CUI [4,2]
C1517925
UMLS CUI [4,3]
C0231175
UMLS CUI [5,1]
C0279492
UMLS CUI [5,2]
C0205539
serum testosterone levels ≥ 125 ng/dl (1.25 ng/ml, 1.25 microg/l, 4.3 nmol/l) measured by any laboratory or on site within the previous 6 months or at study start
Descripción

Serum testosterone measurement

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0428413
karnofsky performance index > 70
Descripción

Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0206065
expected survival ≥ 9 months
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior hormonal treatment for prostate cancer including gonadotropin-releasing hormone (gnrh) agonists or antagonists within the last 12 months preceding the study or concomitant treatment with one or more of these substance(s)
Descripción

Prior Hormone Therapy Prostate carcinoma | GnRH agonists Quantity | GnRH antagonist Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514460
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C2012324
UMLS CUI [2,2]
C1265611
UMLS CUI [3,1]
C1268855
UMLS CUI [3,2]
C1265611
any current use or within 6 months prior to treatment start of medications which are known to affect the metabolism and/or secretion of androgenic hormones: ketoconazole, aminoglutethimide, oestrogens and progesterone
Descripción

Pharmaceutical Preparations Affecting Metabolism | Pharmaceutical Preparations Affecting Androgen secretion | Ketoconazole | Aminoglutethimide | Estrogens | Progesterone

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C0025519
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C0392760
UMLS CUI [2,3]
C3271399
UMLS CUI [3]
C0022625
UMLS CUI [4]
C0002555
UMLS CUI [5]
C0014939
UMLS CUI [6]
C0033308
patient at risk of spinal cord compression or ureter obstruction
Descripción

At risk Compression of spinal cord | At risk Ureteral obstruction

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1444641
UMLS CUI [1,2]
C0037926
UMLS CUI [2,1]
C1444641
UMLS CUI [2,2]
C0041956
prior hypophysectomy or adrenalectomy
Descripción

Hypophysectomy | Adrenalectomy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020632
UMLS CUI [2]
C0001632
Volver a la parte superior de la página

Similar models

Eligibility Prostate Cancer NCT01257425

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Prostate carcinoma Advanced Locally | Metastatic Prostate Carcinoma | Raised prostate specific antigen | Status post Local Therapy failed | Antiandrogen therapy Scheduled
Item
histologically or cytologically proven prostate cancer, locally advanced or metastatic, or rising psa (prostate-specific antigen) after failed local therapy, and the patient scheduled to receive androgen deprivation therapy
boolean
C0600139 (UMLS CUI [1,1])
C0205179 (UMLS CUI [1,2])
C1517927 (UMLS CUI [1,3])
C0936223 (UMLS CUI [2])
C0178415 (UMLS CUI [3])
C0231290 (UMLS CUI [4,1])
C1517925 (UMLS CUI [4,2])
C0231175 (UMLS CUI [4,3])
C0279492 (UMLS CUI [5,1])
C0205539 (UMLS CUI [5,2])
Serum testosterone measurement
Item
serum testosterone levels ≥ 125 ng/dl (1.25 ng/ml, 1.25 microg/l, 4.3 nmol/l) measured by any laboratory or on site within the previous 6 months or at study start
boolean
C0428413 (UMLS CUI [1])
Karnofsky Performance Status
Item
karnofsky performance index > 70
boolean
C0206065 (UMLS CUI [1])
Life Expectancy
Item
expected survival ≥ 9 months
boolean
C0023671 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Prior Hormone Therapy Prostate carcinoma | GnRH agonists Quantity | GnRH antagonist Quantity
Item
prior hormonal treatment for prostate cancer including gonadotropin-releasing hormone (gnrh) agonists or antagonists within the last 12 months preceding the study or concomitant treatment with one or more of these substance(s)
boolean
C1514460 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C2012324 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C1268855 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
Pharmaceutical Preparations Affecting Metabolism | Pharmaceutical Preparations Affecting Androgen secretion | Ketoconazole | Aminoglutethimide | Estrogens | Progesterone
Item
any current use or within 6 months prior to treatment start of medications which are known to affect the metabolism and/or secretion of androgenic hormones: ketoconazole, aminoglutethimide, oestrogens and progesterone
boolean
C0013227 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C0025519 (UMLS CUI [1,3])
C0013227 (UMLS CUI [2,1])
C0392760 (UMLS CUI [2,2])
C3271399 (UMLS CUI [2,3])
C0022625 (UMLS CUI [3])
C0002555 (UMLS CUI [4])
C0014939 (UMLS CUI [5])
C0033308 (UMLS CUI [6])
At risk Compression of spinal cord | At risk Ureteral obstruction
Item
patient at risk of spinal cord compression or ureter obstruction
boolean
C1444641 (UMLS CUI [1,1])
C0037926 (UMLS CUI [1,2])
C1444641 (UMLS CUI [2,1])
C0041956 (UMLS CUI [2,2])
Hypophysectomy | Adrenalectomy
Item
prior hypophysectomy or adrenalectomy
boolean
C0020632 (UMLS CUI [1])
C0001632 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial